These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9013494)

  • 1. The TNF-ligand and receptor superfamilies: controllers of immunity and the Trojan horses of autoimmune disease?
    Hill CM; Lunec J
    Mol Aspects Med; 1996 Oct; 17(5):455-509. PubMed ID: 9013494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily.
    Gruss HJ
    Int J Clin Lab Res; 1996; 26(3):143-59. PubMed ID: 8905447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque.
    Raine CS; Bonetti B; Cannella B
    Rev Neurol (Paris); 1998 Sep; 154(8-9):577-85. PubMed ID: 9809372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
    Gruss HJ; Duyster J; Herrmann F
    Ann Oncol; 1996; 7 Suppl 4():19-26. PubMed ID: 8836404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
    Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immune responses by the ligands for CD27, CD30, and 4-1BB.
    Alderson MR
    Circ Shock; 1994 Oct; 44(2):73-6. PubMed ID: 7743603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
    J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively.
    Kajiwara K; Saito A; Ogata S; Tanihara M
    Biochim Biophys Acta; 2004 Jun; 1699(1-2):131-7. PubMed ID: 15158720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40.
    Starling GC; Kiener PA; Aruffo A; Bajorath J
    Biochemistry; 1998 Mar; 37(11):3723-6. PubMed ID: 9521690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Takeda K; Kobata T; Yagita H; Okumura K; Azuma M; Nagai R
    J Pathol; 2001 Dec; 195(5):593-603. PubMed ID: 11745696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of death receptor pathways in oncology.
    de Vries EG; Timmer T; Mulder NH; van Geelen CM; van der Graaf WT; Spierings DC; de Hooge MN; Gietema JA; de Jong S
    Drugs Today (Barc); 2003; 39 Suppl C():95-109. PubMed ID: 14988748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand.
    Lu G; Janjic BM; Janjic J; Whiteside TL; Storkus WJ; Vujanovic NL
    J Immunol; 2002 Feb; 168(4):1831-9. PubMed ID: 11823516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lymphotoxin-beta-specific receptor.
    Crowe PD; VanArsdale TL; Walter BN; Ware CF; Hession C; Ehrenfels B; Browning JL; Din WS; Goodwin RG; Smith CA
    Science; 1994 Apr; 264(5159):707-10. PubMed ID: 8171323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-related ligands and their receptors.
    Orlinick JR; Chao MV
    Cell Signal; 1998 Sep; 10(8):543-51. PubMed ID: 9794252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF.
    Grell M; Zimmermann G; Gottfried E; Chen CM; Grünwald U; Huang DC; Wu Lee YH; Dürkop H; Engelmann H; Scheurich P; Wajant H; Strasser A
    EMBO J; 1999 Jun; 18(11):3034-43. PubMed ID: 10357816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
    Phillips TA; Ni J; Hunt JS
    Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers.
    Kamiyama H; Kurosaki K; Kurimoto M; Katagiri T; Nakamura Y; Kurokawa M; Sato H; Endo S; Shiraki K
    Cancer Sci; 2004 Dec; 95(12):990-8. PubMed ID: 15596049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.